| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88d168856e5b3ff499581f210bae90f5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P29-00 |
| filingDate |
1987-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2128c7c48203084adef064a3d989957b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49a0c4912a42272170c508eab4190576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfdd5c20f252bc6b323332d6cdde8af3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2994dac61b4007ab30a3b4722c5d7d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58671a58c22c6d6be3a6f79e7f16b137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff35d3b0868064af2380216ef0554cce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb4579323223685c8bd412054a5dfdb2 |
| publicationDate |
1987-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0242695-A1 |
| titleOfInvention |
New anthracycline antibiotics DCP-1 and 2 |
| abstract |
New anthracycline antibiotics of a formula (I) are provided, which are usable as an anticancer agentn (where R represents a hydrogen atom or a hydroxyl group). n The antibiotics (I) can be produced by incubation of a dye-nonproductive or hardly dye-productive mutant strain which has an ability of converting α-citromycinone or β-isorhodomycinone into the antibiotics (I), in the presence of α-citromycinone or β-isorhodomycinone in a pertinent nutrient medium. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0721985-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-614954-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0286926-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0721985-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3712350-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0286926-A3 |
| priorityDate |
1986-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |